Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01NGH
|
|||
| Former ID |
DIB011471
|
|||
| Drug Name |
Multi-envelope HIV vaccine
|
|||
| Synonyms |
PolyEnv1; AIDS vaccine, St Jude; HIV vaccine, St Jude; Multi-envelope AIDS vaccine, St Jude; Multi-envelope HIV vaccine, St Jude; Vaccine (HIV), St Jude
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Phase 1 | [1] | |
| Company |
St Jude Children's Research Hospital
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Human immunodeficiency virus Envelope glycoprotein gp120 (HIV gp120) | Target Info | . | [2] |
| Human immunodeficiency virus Glycoprotein 41 (HIV gp41) | Target Info | . | [2] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00187044) Evaluation of the Safety of a Polyvalent Virus in Healthy Adults. U.S. National Institutes of Health. | |||
| REF 2 | An assessment of the role of chimpanzees in AIDS vaccine research. Altern Lab Anim. 2008 Sep;36(4):381-428. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.